Correspondence 0001104659-24-060514 from PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: May 13, 2024 · CIK: 0001985062 · Accession: 0001104659-24-060514
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276973
Letter
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario MK5 2K1
May 13, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed February 9, 2024, as amended
File No. 333-276973
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on Tuesday, May 14, 2024, or as soon as thereafter practicable.
Very truly yours,
Psyence Biomedical Ltd.
Show Raw Text
CORRESP
1
filename1.htm
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario MK5 2K1
May 13, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed February 9, 2024, as amended
File No. 333-276973
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced
Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on Tuesday, May 14, 2024, or as soon as thereafter practicable.
Very truly yours,
Psyence Biomedical Ltd.
By:
/s/ Neil Maresky
Name: Neil Maresky
Title: Chief Executive Officer
cc: Ellenoff
Grossman & Schole LLP